SCRS Welcomes Bayer as a New Global Impact Partner
Contact:
Mary D’Rozario
Director of Communications
Society for Clinical Research Sites
919.890.5513
mary.drozario@myscrs.org
FOR IMMEDIATE RELEASE
SCRS Welcomes Bayer as a New Global Impact Partner
Ellicott City, MD, July 18, 2017 — The Society for Clinical Research Sites (SCRS) announced today that Bayer is a new Global Impact Partner (GIP). Bayer is a global life science company with core competencies in the areas of health care and agriculture. As a GIP, Bayer will serve on the SCRS Global Impact Board, working with the Leadership Council to set and pursue strategic initiatives.
“As a worldwide clinical trial sponsor, Bayer is an important stakeholder with regard to standards that affect site sustainability,” said SCRS president Christine Pierre. “We are excited to welcome Bayer as a GIP and look forward to collaborating towards our shared goal of strengthening sites.”
Within this collaboration, Bayer will be directly working with clinical trial sites and other industry peers to address challenges of clinical development and drive future improvements.
###
About SCRS
SCRS is a global trade organization founded in 2012 which represents almost 9,000 research sites in over 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.
